logo

FDA Calendar

Company Name IONIS PHARMACEUTICALS INC
IONS
Drug Name Tofersen (NDA)
Event Name FDA panel to review Tofersen for superoxide dismutase 1 amyotrophic lateral sclerosis
Event Date 03/22/2023
Outcome Date
Outcome Pending
Drug Status Biogen licensed Tofersen from Ionis Pharmaceuticals Inc. under a collaborative development and license agreement signed in 2018.
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
President Joe Biden has signed the Covid Origins Act of 2023 into law. The legislation requires the Biden administration to declassify intelligence related to any potential links between the Wuhan Institute of Virology and the origins of the Covid pandemic within 90 days of enactment.
A significant decrease in the number of Covid cases and deaths has been reported in the United States in the past two weeks. Coronavirus infections fell by 34 percent and deaths due to the virus disease reduced by 38 percent nationally, according to the latest data shared by the New York Times. Other Covid metrics also indicate the slowing down of the pandemic. Hospitalizations have been fallin
The Department of Health and Human Services has unveiled the first set of Part B prescription drugs that will be subject to Medicare inflation rebates because they raised their prices faster than inflation. Under prescription drug law, prescription drug companies have to pay back Medicare if they raise prices on seniors at a higher rate than inflation. From next month, some Medicare beneficiar
Read More